Skip Ribbon Commands
Skip to main content
SharePoint
Manage PermissionsManage Permissions
|
Export Event

Title

Counting Cards In BioTech, Mike Caldwell, Driehaus

Event Description

Driehaus, Michael Caldwell, February 19, 2020, 12PM, The City Club


Luncheon Sponsored by



 

Counting Cards in Biotech

 

Many investors believe early stage biotech companies are a gamble. As a result, most managers avoid the industry entirely or employ a diversified basket approach for exposure, hoping that a few big winners can offset losing positions. We believe a better approach exists to capitalize on the exciting opportunity-set in therapeutics over the next decades. The central pillar of our biotech investment philosophy at Driehaus is the observation that markets systematically misprice the probability of success in development stage biotech companies, and this inefficiency can be repeatably and sustainably exploited. By focusing on the key determinants of a product’s ultimate success (biology and clinical strategy), we believe an opportunity exists to “count cards.”

Join us for a discussion of the framework Mike and his team developed over the last decade for investing in the biotech industry. We’ll also share views on where we believe opportunities and risks lie going forward, as well as the significant impact we believe genomics will have on how healthcare is delivered in the future.

Michael Caldwell is a portfolio manager and a senior analyst on the US Growth Equities Team with a focus on the health care sector.  His in-depth fundamental research, idea generation and buy/sell recommendations are leveraged across all four of the strategies managed by the Driehaus US Growth Equities Team.  Additionally, specific to the Driehaus Life Sciences and Driehaus Event Driven strategies, Mr. Caldwell acts as a portfolio manager and is also responsible for security selection, portfolio construction and risk management.

Mr. Caldwell has been investing in healthcare equities for more than a decade and has analyzed, followed, and interacted with management of most small cap healthcare companies in the Russell 3000. Prior to joining Driehaus in 2007, Mr. Caldwell worked as a graduate research  associate for the Department of Biomedical Engineering at Yale University.
Mr. Caldwell received his B.S. in biomedical engineering from Yale University.

Twitter: @DriehausCapital

https://twitter.com/DriehausCapital?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

LinkedIn: https://www.linkedin.com/company/driehaus-capital-management/

 


Event Type

Career; Featured

Education Topic

 

Start Time

2/19/2020 12:00 PM

End Time

2/19/2020 1:30 PM

City

Cleveland

State/Province

Ohio

Event Country

USA

Event Region

Americas

Location Info

The City Club
850 Euclid Avenue Floor 2
Cleveland, Ohio 44114​

Speaker

Mike Caldwell

CE Credits

Yes

SER Credit

No

Currency

$

Member Price

$0

Non-Member Price

$40

Candidate Price

$25

Registration

All Day Event

 

Recurrence

 

Image

 

Recording

 

End

2/19/2020 1:30 PM

Event Link

Counting Cards In BioTech, Mike Caldwell, Driehaus

Event Link Leads To New Tab

Yes

Event Short Info

Counting Cards In BioTech, Mike Caldwell, Driehaus

Attachments

Content Type: MyCFA Calendar
Created at 11/12/2019 10:09 AM by cfa@cleveland.cfasociety.org
Last modified at 12/3/2019 11:53 AM by cfa@cleveland.cfasociety.org